About Shalina Laboratories Private Limited
Data last updated:
Shalina Laboratories Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 December 1984.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1984PTC034786. Its GSTIN is 27AABCS1423M1ZD (Maharashtra).
The company had an authorised share capital of ₹8.4 Cr and a paid-up capital of ₹8.38 Cr. It was formerly known as Shalina Laboratories Limited. It was led by directors including Sundar Sankaran and Neelam Virji.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at 96 Maker Chamber Vinariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2023, the company reported a revenue of ₹551.12 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹27.87 Cr (net margin 5.1%) and EBITDA of ₹47 Cr (EBITDA margin 8.5%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 8% over five years.
The company had about 314 employees on its provident fund (EPFO) records before it was dissolved.
As per MCA filings, the company had satisfied charges of ₹143.1 Cr on record. Court records list 6 cases involving the company, including 4 filed by the company and 2 filed against it.
The last known website on record is shalina.com.
Company details
Contact details
Shalina Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its website is shalina.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address96 Maker Chamber Vinariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shalina Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Shalina Laboratories are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Shalina Laboratories Private Limited, buy the company report.
Financials of Shalina Laboratories Private Limited
FY 2023 filings availableShalina Laboratories Private Limited reported revenue of ₹551.12 Cr (down 1% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 8%. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹551.12 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹47 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹27.87 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.5% | ||||
| Net Profit Margin | 5.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shalina Laboratories Private Limited, buy the company report.
Board of directors and KMP of Shalina Laboratories Private Limited
Shalina Laboratories Private Limited currently reports 4 directors and 1 key managerial person. 10 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sundar Sankaran Also directs: Shalina Trading Co Pvt Ltd, Shalina Pharmaceuticals Private Limited, Shalina Laboratories Private Limited and 2 more | Director | 12 Mar 2011 | 15 Years 7 Months | As last reported |
| Neelam Virji Also directs: Shalina Trading Co Pvt Ltd | Director | 30 May 2006 | 20 Years 5 Months | As last reported |
| Shalina Clifford | Director | 10 Feb 2015 | 11 Years 9 Months | As last reported |
| Fazle Abbas Virji | Director | 10 Feb 2015 | 11 Years 9 Months | As last reported |
| Sushil Kumar Agarwal | Company Secretary | 01 Apr 2013 | 13 Years 7 Months | As last reported |
Peer comparison
Shalina Laboratories Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Acme Formulation Private Limited | ₹577 Cr (FY 2025) | -2.0% | Himachal Pradesh, India | |||
| Bajaj Healthcare Limited | ₹562.01 Cr (FY 2025) | 17.0% | Thane, Maharashtra, India | |||
| G S Pharmbutor Private Limited | ₹561.56 Cr (FY 2025) | 6.0% | Rudrapur, Uttarakhand, India | |||
| Ind Swift Limited | ₹560.24 Cr (FY 2024) | 33.0% | Chandigarh, India | |||
| Shalina Laboratories Private Limitedthis company | ₹551.12 Cr (FY 2023) | ₹27.87 Cr | 5.1% | -1.0% | 314 | Mumbai, Maharashtra, India |
| German Remedies Pharmaceuticals Private Limited | ₹546.98 Cr (FY 2025) | 9.0% | Ahmedabad, Gujarat, India | |||
| Graviti Pharmaceuticals Private Limited | ₹543.75 Cr (FY 2025) | 17.0% | Hyderabad, Telangana, India | |||
| Kusum Healthcare Private Limited | ₹537.89 Cr (FY 2025) | 10.0% | New Delhi, Delhi, India | |||
| Unison Pharmaceuticals Private Limited | ₹537.1 Cr (FY 2025) | 23.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Shalina Laboratories Private Limited, buy the company report.
Auditor
Shalina Laboratories Private Limited is audited by S R B C & Co. LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R B C & Co. LLP | FY 2023 | 324982E/E300003 |
Shareholding
The shareholding of Shalina Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Shalina Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Oct 2019 | 100298889 | Standard Chartered Bank | ₹14 Cr | Satisfied | |
| 17 Sep 2019 | 100287833 | Standard Chartered Bank | ₹25 Cr | Satisfied | |
| 06 Aug 2008 | 10122819 | Icici Bank Limited | ₹12 Cr | Satisfied | |
| 18 Aug 2005 | 90241553 | Uti Bank Ltd | ₹12 Cr | Satisfied | |
| 17 Sep 2002 | 90236184 | State Bank of India | ₹1.8 Cr | Satisfied |
To see the full charge records of Shalina Laboratories Private Limited, buy the company report.
Total charge records: 11 View all charges
Legal cases
Shalina Laboratories Private Limited has 6 court cases on record: 4 filed by Shalina Laboratories, 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 2 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (S) | Filed by the company against Avik Pharmaceuticals Ltd. | Disposed |
| Bombay High Court | Tax appeal | Filed against the company by The Commissioner of Income Tax-3,Mumbai | Disposed |
| Bombay High Court | Court case (CHOCL) | Filed by the company against M/S. Rajat Enterprises and Ors. | Disposed |
| Bombay High Court | Writ petition | Filed against the company by an individual | Disposed |
| Bombay High Court | Court case (CHS) | Filed by the company against Rajat Enterprises and 3 Ors | Disposed |
To see the full case history of Shalina Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Shalina Laboratories Private Limited was last rated by Crisil on 27 Nov 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 27 Nov 2019 |
To see the full credit ratings and regulatory alerts of Shalina Laboratories Private Limited, buy the company report.
MSME payment delays
Shalina Laboratories Private Limited has 19 MSME Form 1 returns on record between 2017 and 2023, listing 2,009 overdue payments to 126 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 126)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Capsugel Healthcare Private Limited | |||
| an individual supplier | |||
| Pehel Specialities LLP | |||
| Anand Enterprises | |||
| V N Pharma |
To see the full MSME payment records of Shalina Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Shalina Laboratories Private Limited has a workforce of 314 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Shalina Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCS1423M1ZD | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Shalina Laboratories Private Limited, buy the company report.
Recent activity
Shalina Laboratories Private Limited has 15 board changes on record since 2006: 5 appointments and 10 cessations. The latest: Desh Deepak Misra ceased to be Director on 30 Sep 2021.
34 earlier events are in the company report.
Frequently asked questions
Shalina Laboratories has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Shalina Laboratories was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 13 December 1984 and is registered under CIN U24239MH1984PTC034786. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Shalina Laboratories was incorporated on 13 December 1984. It is registered with the Registrar of Companies, Mumbai.
Shalina Laboratories had 5 directors and KMP:
- Sundar Sankaran - Director
- Neelam Virji - Director
- Shalina Clifford - Director
- Fazle Abbas Virji - Director
- Sushil Kumar Agarwal - Company Secretary
The CIN (Corporate Identification Number) of Shalina Laboratories is U24239MH1984PTC034786. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Shalina Laboratories is at 96 Maker Chamber Vinariman Point, Mumbai, Maharashtra, India – 400021.
Shalina Laboratories can be reached through the website shalina.com. Its registered office is in Mumbai, Maharashtra, India.
The latest financial statements of Shalina Laboratories on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Shalina Laboratories is 27AABCS1423M1ZD, registered in Maharashtra.
Shalina Laboratories operated in the pharma industry, in the drug formulation and development segment.
The peers of Shalina Laboratories by revenue are Acme Formulation Private Limited, Bajaj Healthcare Limited, G S Pharmbutor Private Limited, Ind Swift Limited, German Remedies Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shalina Laboratories has 19 MSME Form 1 returns on record between 2017 and 2023, listing 2,009 overdue payments to 126 micro and small suppliers. The latest return was filed on 17 Nov 2023.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
